MARKET

MIRM

MIRM

Mirum Pharmaceuticals
NASDAQ
89.70
+0.34
+0.38%
After Hours: 90.06 +0.36 +0.40% 19:56 09/25 EDT
OPEN
89.90
PREV CLOSE
89.36
HIGH
90.81
LOW
88.28
VOLUME
765.80K
TURNOVER
--
52 WEEK HIGH
130.00
52 WEEK LOW
63.23
MARKET CAP
5.82B
P/E (TTM)
-6.1661
1D
5D
1M
3M
1Y
5Y
1D
Mirum and Incyte gain approval of zilurgisertib for rare bone disorder
Seeking Alpha · 15h ago
Mirum Pharmaceuticals, Incyte announce FDA approval of Atebrioz
TipRanks · 1d ago
3 things to look out for on Friday
Seeking Alpha · 2d ago
Weekly Report: what happened at MIRM last week (0914-0918)?
Weekly Report · 5d ago
Catalyst Watch: Trump-Xi in DC, Meta Connect, and McDonald's Investor Day
Seeking Alpha · 09/18 19:10
Mirum Pharmaceuticals: Oversold And Set To Rally On Critical Pipeline-Related Events
Seeking Alpha · 09/16 16:12
Mirum Pharmaceuticals: The September PDUFA Is The Smallest Catalyst
Seeking Alpha · 09/15 13:19
Weekly Report: what happened at MIRM last week (0907-0911)?
Weekly Report · 09/14 10:29
More
About MIRM
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the treatment of rare diseases affecting children and adults. It has three medicines: LIVMARLI (maralixibat) oral solution (Livmarli), Cholbam (cholic acid) capsules, and Chenodal or Ctexli (chenodiol) tablets. Livmarli is an orally administered, minimally-absorbed ileal bile acid transporter (IBAT) inhibitor (IBATi) that is used for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS) in the United States and various other countries and for cholestatic pruritus in patient with progressive familial intrahepatic cholestasis (PFIC) in the United States, Canada and Japan. Cholbam is used for the treatment of bile acid synthesis disorders due to single enzyme deficiencies and adjunctive treatment of peroxisomal disorders. The Company is also advancing its product candidate, volixibat, for the treatment of adult patients with cholestatic liver diseases.

Webull offers Mirum Pharmaceuticals Inc stock information, including NASDAQ: MIRM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MIRM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MIRM stock methods without spending real money on the virtual paper trading platform.